Business Context and Reporting Period
This Form 8-K is filed by Sema4 Holdings Corp. (noting the metadata reference to GeneDx Holdings, which was acquired by Sema4 in April 2022) on June 14, 2022, reporting events occurring on June 10, 2022. The filing addresses significant executive leadership changes, specifically the departure of the Chief Financial Officer and the appointment of an interim replacement, alongside amendments to executive compensation agreements.
Key Financial Metrics
This filing is a current report regarding corporate governance and personnel changes. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. No financial statements are included in this document.
Material Changes and Executive Actions
- Departure of CFO: Isaac Ro is departing as Chief Financial Officer to pursue other opportunities. His last day of employment is August 9, 2022.
- Appointment of Interim CFO: Richard Miao, previously Senior Vice President of Financial Planning & Analysis and Treasurer, was promoted to Deputy Chief Financial Officer and appointed Interim Chief Financial Officer effective June 13, 2022.
- Compensation Adjustments:
- Isaac Ro (Outgoing): Entitled to nine months of salary continuation and twelve months of COBRA benefits upon execution of a release. He will also enter a six-month consulting agreement for advisory services, with continued equity vesting and an additional six months of partial accelerated vesting upon completion.
- Richard Miao (Incoming): Approved a total annual base salary of $360,000, a target annual bonus of 50% of base salary, and a $100,000 cash retention bonus payable three months after the permanent CFO's start date.
- Executive Agreement Amendment: An amendment was executed with Dr. Eric Schadt (President and Chief Research & Development Officer) extending the period to provide notice of "Good Reason" regarding his appointment through April 28, 2023.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, forward-looking outlook statements, or specific risk factors beyond the operational transition of the CFO role. The company is currently conducting a search to fill the Chief Financial Officer position on a permanent basis.
Key Facts for Investor Verification
- Verify the timeline for the permanent CFO search and the duration of the interim arrangement.
- Confirm the total cost of the transition package for the outgoing CFO, including the value of the consulting agreement and accelerated equity vesting.
- Review the specific terms of the "Good Reason" amendment for Dr. Eric Schadt to understand potential severance liabilities.
- Monitor future filings for the appointment of a permanent CFO and any associated compensation disclosures.